OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Programming therapeutic probiotics by self-tunable sense-and-respond genetic circuits
Yuxin Liu, Zhengming Zhu, Ling Jiang
Trends in Microbiology (2023) Vol. 31, Iss. 11, pp. 1099-1101
Closed Access | Times Cited: 6
Yuxin Liu, Zhengming Zhu, Ling Jiang
Trends in Microbiology (2023) Vol. 31, Iss. 11, pp. 1099-1101
Closed Access | Times Cited: 6
Showing 6 citing articles:
Engineered Bacteria for Disease Diagnosis and Treatment Using Synthetic Biology
Kai Jin, Yi Huang, Hailong Che, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access
Kai Jin, Yi Huang, Hailong Che, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 1
Open Access
Engineering a novel probiotic toolkit in Escherichia coli Nissle1917 for sensing and mitigating gut inflammatory diseases
Nathalie Weibel, Martina Curcio, Atilla Schreiber, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Nathalie Weibel, Martina Curcio, Atilla Schreiber, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Engineering a Novel Probiotic Toolkit in Escherichia coli Nissle 1917 for Sensing and Mitigating Gut Inflammatory Diseases
Nathalie Weibel, Martina Curcio, Atilla Schreiber, et al.
ACS Synthetic Biology (2024) Vol. 13, Iss. 8, pp. 2376-2390
Open Access | Times Cited: 1
Nathalie Weibel, Martina Curcio, Atilla Schreiber, et al.
ACS Synthetic Biology (2024) Vol. 13, Iss. 8, pp. 2376-2390
Open Access | Times Cited: 1
Genetically engineered bacteria as inflammatory bowel disease therapeutics
Zhen‐Ping Zou, Xiao-Peng Zhang, Qian Zhang, et al.
Engineering Microbiology (2024) Vol. 4, Iss. 4, pp. 100167-100167
Open Access | Times Cited: 1
Zhen‐Ping Zou, Xiao-Peng Zhang, Qian Zhang, et al.
Engineering Microbiology (2024) Vol. 4, Iss. 4, pp. 100167-100167
Open Access | Times Cited: 1
Clostridium tyrobutyricum in Combination with Chito-oligosaccharides Modulate Inflammation and Gut Microbiota for Inflammatory Bowel Disease Treatment
Zhenlei Liu, Pengfei Bai, Lefei Wang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 33, pp. 18497-18506
Closed Access
Zhenlei Liu, Pengfei Bai, Lefei Wang, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 33, pp. 18497-18506
Closed Access
Delivery of Encapsulated Intelligent Engineered Probiotic for Inflammatory Bowel Disease Therapy
Zhen‐Ping Zou, Zhihao Cai, Xiao Peng Zhang, et al.
Advanced Healthcare Materials (2024)
Closed Access
Zhen‐Ping Zou, Zhihao Cai, Xiao Peng Zhang, et al.
Advanced Healthcare Materials (2024)
Closed Access
